✦ LIBER ✦

Expression of C-Kit & PDGFRα and correlation with chemotherapy resistance in ovarian serous carcinomas: a clinical study

✍ Scribed by Cunjian Yi; Li Li; Ding Ma

Book ID: 106314943
Publisher: Springer
Year: 2009
Tongue: English
Weight: 292 KB
Volume: 8
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-009-0020-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical detection of human t

Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: A clinicopathologic study

✍ Hermann Brustmann 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 384 KB

IMMUNOHISTOCHEMICAL ANALYSIS OF EGFR, C-

IMMUNOHISTOCHEMICAL ANALYSIS OF EGFR, C-ERBB-2 AND PDGFR-α EXPRESSION: CORRELATION WITH CLINICAL DATA AND EARLY BIOCHEMICAL RELAPSE IN KOREAN UNDERGOING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALISED PROSTATE CANCERS

✍ S.J. Jeong; J.S. Jeong; B.K. Han; J.H. Kim; K.H. Moon; S.K. Hong; S.S. Byun; G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

A prospective analysis of imatinib-induc

A prospective analysis of imatinib-induced c-kit modulation in ovarian cancer : A phase II clinical study with proteomic profiling

✍ Edwin M. Posadas; Virginia Kwitkowski; Herbert L. Kotz; Virginia Espina; Lori Mi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

## Abstract ## BACKGROUND. c‐Kit and platelet‐derived growth factor receptor (PDGFR) are potential molecular targets in epithelial ovarian cancer (EOC). Imatinib inhibits the kinase domain and subsequent downstream signaling of these receptor tyrosine kinases. The objective of this study was to in

A Prospective Study of p53 Expression an

A Prospective Study of p53 Expression and Its Correlation With Clinical Response of Radiotherapy in Nasopharyngeal Carcinoma

✍ Kuen-Yao Ho; Wen-Rei Kuo; Chee-Yin Chai; Shih-Meng Tsai; Sheng-Hsiung Sheu; Shu- 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 743 KB

Expression of multidrug resistance-1 pro

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples

✍ Richard T Penson; Esther Oliva; Steven J Skates; Tina Glyptis; Arlan F Fuller Jr 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 359 KB

Phase II clinical trial of capecitabine

Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6–12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study

✍ Agustin A. Garcia; John A. Blessing; Heinz-Josef Lenz; Kathleen M. Darcy; Robert 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 132 KB